Back to Opportunities
grant
Open
Immune Tolerance Network (UM1 Clinical Trial Required)
National Institutes of Health· United States
Summary
This is a National Institutes of Health funding opportunity for the Immune Tolerance Network under the UM1 Clinical Trial Required mechanism. It is a posted grant notice with a stated deadline of 2027-01-29. The notice indicates applicants must propose clinical trial research.
Description
National Institutes of Health — Immune Tolerance Network (UM1 Clinical Trial Required). CFDA: 93.855. Status: posted.